Ayan Dey
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- Endocrinology top 10%
Papers in
-
- Research on Leishmaniasis Studies 9
-
- Trypanosoma species research and implications 8
- Co-authors
- Sarman Singh (10 shared papers)Cécil Czerkinsky (6 shared papers)Kevinkumar Kansagra (2 shared papers)Jayesh Sanmukhani (2 shared papers)Jae Seung Yang (4 shared papers)Giulietta Saletti (3 shared papers)Sivakumar Ramu (2 shared papers)Nicolas Çuburu (1 shared paper)
- Journals
- Clinical and Vaccine Immunology (5 papers)Vaccine (4 papers)Heliyon (2 papers)Infection Genetics and Evolution (2 papers)Nature Protocols (1 paper)
- Partner nations
- IndiaSouth KoreaUnited States
In The Last Decade
Ayan Dey
25 papers receiving 840 citations
Ayan Dey's Hit Papers
Peers
Comparison fields: 5 of 71
- Infectious Diseases 384
- Endocrinology 59
- Health 78
- Public Health, Environmental and Occupational Health 248
- Immunology 167
Countries citing papers authored by Ayan Dey
This map shows the geographic impact of Ayan Dey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayan Dey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayan Dey more than expected).
Fields of papers citing papers by Ayan Dey
This network shows the impact of papers produced by Ayan Dey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayan Dey. The network helps show where Ayan Dey may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayan Dey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India Hit paper breakdown → | 2022 | 166 |
| 2 | 2021 | 130 | |
| 3 | 2021 | 95 | |
| 4 | 2006 | 82 | |
| 5 | 2013 | 76 | |
| 6 | Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. | 2013 | 34 |
| 7 | 2005 | 30 | |
| 8 | 2006 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2008 | 26 | |
| 11 | 2015 | 22 | |
| 12 | 2017 | 21 | |
| 13 | 2017 | 20 | |
| 14 | 2007 | 20 | |
| 15 | 2008 | 16 | |
| 16 | 2014 | 15 | |
| 17 | 2006 | 14 | |
| 18 | 2009 | 10 | |
| 19 | 2015 | 9 | |
| 20 | 2018 | 9 |
About Ayan Dey
Ayan Dey is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology, Infectious Diseases, Immunology and Endocrinology, having authored 25 papers that have together received 880 indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (8 papers), Viral gastroenteritis research and epidemiology (4 papers), Immunotherapy and Immune Responses (3 papers), Escherichia coli research studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Vibrio bacteria research studies (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Infectious Diseases (384 citations), Endocrinology (59 citations), Health (78 citations), Public Health, Environmental and Occupational Health (248 citations) and Immunology (167 citations). Ayan Dey has collaborated with scholars based in India, South Korea and United States. Frequent co-authors include Sarman Singh, Cécil Czerkinsky, Kevinkumar Kansagra, Jayesh Sanmukhani, Jae Seung Yang, Giulietta Saletti, Sivakumar Ramu, Nicolas Çuburu, Kapil Maithal and Harish Chandra. Their work appears in journals such as Clinical and Vaccine Immunology, Vaccine, Heliyon, Infection Genetics and Evolution and Nature Protocols.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.